MRNX (Defiance Daily Target 2X Long MRNA ETF) Stock Analysis - Hedge Fund Holdings

Defiance Daily Target 2X Long MRNA ETF (MRNX) is a publicly traded the market company. As of May 21, 2026, MRNX trades at $27.10 with a market cap of $0 and a P/E ratio of 0.00. MRNX moved -3.43% today. Year to date, MRNX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces MRNX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns MRNX stock?

Rallies tracks hedge fund and 13F ownership for MRNX, including fund holders, share counts, and position changes when data is available.

MRNX Key Metrics

Key financial metrics for MRNX
MetricValue
Price$27.10
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume171.29K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest MRNX News

MRNX Analyst Consensus

MRNX analyst coverage data. Average price target: $0.00.

Common questions about MRNX

Who owns MRNX stock?
Rallies tracks hedge fund and 13F ownership for MRNX, including fund holders, share counts, and position changes when data is available.
Does Rallies show 13F holders for MRNX?
Yes. Rallies tracks hedge fund and 13F ownership data for MRNX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is MRNX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MRNX. It does not provide personalized investment advice.
MRNX

MRNX